CROHNS DISEASE

This study looked at how safe the drug guselkumab is for people with moderate to severe Crohn's disease. 38 adults received the drug and were monitored for side effects and how well their symptoms improved over 48 weeks. The main goal was to track any negative reactions, includin…

This early-stage study tested a new drug called AZD7798 in 112 healthy volunteers and people with Crohn's disease. The main goal was to check if the drug is safe and how the body processes it. No treatment benefits were expected at this phase.

This study looked at 646 people with complex fistulas caused by Crohn's disease or other conditions. Researchers observed how well standard surgeries worked in real clinics, without changing any treatments. The goal was to gather real-world evidence on healing and complications, …

This study observed 92 adults with Crohn's disease or ulcerative colitis who were already taking or starting vedolizumab. Researchers watched whether patients chose intravenous infusions at a clinic or injections at home, and how long they stayed on their chosen treatment. The go…